AXOL BIOSCIENCE LTD.

Company Overview

Axol Bioscience specializes in human cell culture. The company sells primary cells, iPSC-derived cells, cell lines, disease models, and the media and reagents required to culture these cells. Axol is headquartered and maintains production in the Chesterford Research Park in Cambridge, U.K. The company’s iPSC-derived cells include neural cells, astrocytes, cortical neurons, and dopaminergic neurons from healthy and patient donors, covering Alzheimer’s, Huntington’s, and Parkinson’s diseases.

Axol also offers iPSC-derived cardiomyocytes. Axol provides a range of primary cells, including peripheral blood mononuclear cells (PBMCs) and fibroblasts from healthy and diseased backgrounds, covering autoimmune conditions, neurodegenerative disorders, leukemias, and other cancers. Axol also does iPSC reprogramming and differentiation with patient-derived samples to various cell types as a service for customers.

Company's Business Segments

• iPSC Technology : This segment uses iPSCs to build more relevant models of human disease to expand understanding and de-risk Drug Development.